Science and technology awards

Taiwan's 2020 Tang Prize Biopharmaceutical Science Laureates to Decipher the Code of Body's Inflammatory Responses

Monday, September 14, 2020 - 1:00pm

The Tang Prize Foundation, in collaboration with Experimental Biology of the US and Taiwan's National Cheng Kung University, will stage the 2020 Tang Prize Masters' Forum for Biopharmaceutical Science at 9a.m., Taiwan time (GMT+8), on September 22, and livestream it on the Foundation's website (https://www.tang-prize.org/en/week.php?cat=94 ), with both Mandarin and English settings available.

Key Points: 
  • The Tang Prize Foundation, in collaboration with Experimental Biology of the US and Taiwan's National Cheng Kung University, will stage the 2020 Tang Prize Masters' Forum for Biopharmaceutical Science at 9a.m., Taiwan time (GMT+8), on September 22, and livestream it on the Foundation's website (https://www.tang-prize.org/en/week.php?cat=94 ), with both Mandarin and English settings available.
  • In addition to the lectures delivered by three 2020 awardees, 2014 Tang Prize and 2018 Nobel Prize winners Dr. James P. Allison and Prof. Tasuku Honjo will also take part.
  • Harkening back to the golden age of the Tang Dynasty in Chinese history, the Tang Prize seeks to be an inspiring force for people working in all corners of the world.
  • For more information on the Tang Prize and its laureates, please visit www.tang-prize.org

2021 Vilcek Foundation Prizes in Biomedical Science Recognize Immigrant Leaders in STEM

Tuesday, September 8, 2020 - 5:00pm

NEW YORK, Sept. 8, 2020 /PRNewswire/ --The Vilcek Foundation is pleased to announce the recipients of the 2021 Vilcek Foundation Prizes in Biomedical Science.

Key Points: 
  • NEW YORK, Sept. 8, 2020 /PRNewswire/ --The Vilcek Foundation is pleased to announce the recipients of the 2021 Vilcek Foundation Prizes in Biomedical Science.
  • Awarded annually, these awards comprising the Vilcek Prize in Biomedical Science and three Vilcek Prizes for Creative Promise in Biomedical Science honor the contributions of immigrants to scientific research, discovery, and innovation in the United States.
  • The Vilcek Prize in Biomedical Science recognizes an immigrant scientist for outstanding career contributions to biomedical science and global scientific research.
  • The Vilcek Foundation has also announced the recipients of the 2021 Vilcek Prize and Vilcek Prizes for Creative Promise in Filmmaking, and the 2021 Vilcek Prize for Excellence in Public Service.

Sigilon Therapeutics to Participate in Three Upcoming Investor Conferences

Friday, August 7, 2020 - 12:00pm

Sigilon Therapeutics, Inc., a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics platform, today announced that Chief Executive Officer, Rogerio Vivaldi, M.D., will participate in three upcoming virtual investor conferences.

Key Points: 
  • Sigilon Therapeutics, Inc., a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics platform, today announced that Chief Executive Officer, Rogerio Vivaldi, M.D., will participate in three upcoming virtual investor conferences.
  • Sigilon Therapeutics seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics platform.
  • The engineered cells are protected by Sigilons Afibromer biomaterials matrix, which shields them from immune rejection and fibrosis.
  • Sigilon was founded by Flagship Pioneering in conjunction with Daniel Anderson, Ph.D., and Robert Langer, Sc.D., of the Massachusetts Institute of Technology.

SK Innovation Opens Next-Generation Battery Era Together with Nobel Laureate John Goodenough

Thursday, July 30, 2020 - 1:00pm

SEOUL, South Korea, July 30, 2020 /PRNewswire/ --SK innovation announced that it will develop next-generation battery technology with Professor John Goodenough, a 2019 Nobel laureate in chemistry who is known as the father of the lithium-ion battery.

Key Points: 
  • SEOUL, South Korea, July 30, 2020 /PRNewswire/ --SK innovation announced that it will develop next-generation battery technology with Professor John Goodenough, a 2019 Nobel laureate in chemistry who is known as the father of the lithium-ion battery.
  • "Together with SK innovation, I hope we can open the next-generation battery era," said Goodenough.
  • Dr. Seongjun Lee, Chief Technology Officer of SK innovation, said, "We are delighted to announce that SK innovation and Professor Goodenough's group are jointly preparing for the next-generation battery era.
  • Fitted with the complete value chain for battery production, SK innovation is enhancing its global status through partnerships with automakers.